COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1809: Articles 18081-18090  | Next

Was R<1 before the English lockdowns? On modelling mechanistic detail, causality and inference about Covid-19
Wood, S. N., Wit, E. C.
10.1101/2021.02.03.21251112 — Posted: 2021-02-06 Discussion: Onsite
Assessing knowledge, concerns, and risk perceptions among Italian medical students during the SARS-CoV-2 pandemic.
Greco, M., Maietti, E., Savoia, E., Trere, D., Reno, C., Rallo, F., Fantini, M. P., GORI, D.
10.1101/2021.02.04.21250922 — Posted: 2021-02-06
Convalescent Plasma and Improved Survival in Patients with Hematologic Malignancies and COVID-19
Thompson, M. A., Henderson, J. P., Shah, P. K., Rubinstein, S. M., Joyner, M. J., Choueiri, T. K., Flora, D. B., Griffiths, E. A., Gulati, A. P., Hwang, C., Koshkin, V. S., Papadopoulos, E. B., Robilotti, E. V., Su, C. T., Wulff-Burchfield, E. M., Xie, Z., Yu, P. P., Mishra, S., Senefeld, J. W., Shah, D. P., Warner, J. L., COVID-19 and Cancer Consortium
10.1101/2021.02.05.21250953 — Posted: 2021-02-05
Efficacy of Ivermectin in COVID-19 Patients with Mild to Moderate Disease
Bukhari, S. K. H. S., Asghar, A., Perveen, N., Hayat, A., Mangat, S. A., Butt, K. R., Abdullah, M., Fatima, T., Mustafa, A., Cheema, T.
10.1101/2021.02.02.21250840 — Posted: 2021-02-05
Exponential increase in neutralizing and spike specific antibodies following vaccination of COVID-19 convalescent plasma donors
Vickers, M., Sariol, A., Leon, J., Ehlers, A., Locher, A., DuBay, K., Collins, L., Voss, D., Odle, A., Holida, M., Merrill, A., Perlman, S., Knudson, M.
10.1101/2021.02.02.21250836 — Posted: 2021-02-05
Can a COVID-19 vaccination program guarantee the return to a pre-pandemic lifestyle?
Yang, J., Marziano, V., Deng, X., Guzzetta, G., Zhang, J., Trentini, F., Cai, J., Poletti, P., Zheng, W., Wang, W., Wu, Q., Zhao, Z., Dong, K., Zhong, G., Viboud, C., Merler, S., Ajelli, M., Yu, H.
10.1101/2021.02.03.21251108 — Posted: 2021-02-05
Pharmacokinetics of Orally Administered GS-441524 in Dogs
Yan, V. C., Khadka, S., Arthur, K., Ackroyd, J. J., Georgiou, D. K., Muller, F. L.
10.1101/2021.02.04.429674 — Posted: 2021-02-05
Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation
Zhang, L., Mann, M., Syed, Z., Reynolds, H. M., Tian, E., Samara, N. L., Zeldin, D. C., Tabak, L. A., Ten Hagen, K. G.
10.1101/2021.02.05.429982 — Posted: 2021-02-05
Serological Profile Of Specific Antibodies Against Dominant Antigens Of SARS-CoV-2 In Chilean COVID-19 Patients.
Cereceda, K., Gonzalez-Stegmaier, R., Briones, J. L., Selman, C., Aguirre, A., Valenzuela-Nieto, G., Caglevic, C., Gazitua, R., Rojas-Fernandez, A., Villaroel-Espindola, F.
10.1101/2021.02.05.429566 — Posted: 2021-02-05
Protein glycosylation is essential for SARS-CoV-2 infection
Casas-Sanchez, A., Romero-Ramirez, A., Hargreaves, E., Patterson, E. I., Hughes, G. L., Zech, T., Acosta-Serrano, A.
10.1101/2021.02.05.429940 — Posted: 2021-02-05 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).